text:
urEssential Award
JUN 7 - SEP 30, 2016
A Virtual Destination for Laboratory Professionals
Cardinal Health™ labXchange: A breakthrough idea for a non-traditional tradeshow
Cardinal Health™ labXchange is a no-cost online destination where lab professionals have access to exhibits, live webinars and product demonstrations in one convenient location. Hear from leading experts on industry related topics - reimbursements, big data, emerging diseases, IQCP and more. It runs from June 7 to September 30, 2016.
Here are some of the benefits you'll get with your labXchange registration:
Continuing Education credits at NO COST to you offered with several webinars covering an array of industry topics
No travel expenses – a Wi-Fi connection is your ticket into the show
Real-time interaction with industry experts, exhibitors and peers
On-demand content is available 24/7.
Live events coming up:
September 13–14: live educational webinars and product demonstrations
Available on-demand now through September 30, 2016:
Several CE accredited webinars covering an array of industry-related topics
Product demonstrations by clinical diagnostic suppliers
Poster Hall showcasing students' research
Exhibit Hall with 15+ supplier booths
Cardinal Health™ Virtual Lab
Register now to get started. More information is available on the Agenda tab located at the top of the page.
*Continuing Education
By watching the webcast presentations, you can earn Continuing Education (CE) credits at NO COST to you. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.
For Cardinal Health Registration Terms & Conditions Click here
Email cahlabxchange@cardinalhealth.com with any questions.
NOV 09, 2022 6:00 AM PST
Clinical Diagnostics & Research 2022
Thirteen years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2022 Clinical Diagnostics and Research Virtual Event will again bring together clinic...
Microbiology Virtual Week 2022
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 8th Annu...
MAY 04, 2022 5:30 AM PDT
Coronavirus Virtual Event Series
A novel coronavirus emerged in China in late 2019; it has since been dubbed 2019-nCoV. Labroots will be working to educate the community about this...
LabRoots is excited to announce our 10th Annual Genetics Virtual Week held on April 19-21, 2022! Genetics Virtual Week 2022 will offer a multi-day content-rich program combining stellar expe...
LabRoots is pleased to announce the 5th Annual 2021 Cannabis Sciences Virtual Event . LabRoots will host the event on March 23, 2022. The Cannabis Sciences planning committee will be plannin...
JAN 25, 2022 1:00 AM PST
Europe - 10:00 AM Central European Time United Kingdom - 10:00 AM British Summer Time North America - 10:00 AM Central Standard Time Lab Compliance Connect – The world's leading...
Presentations Share
SEP 14, 2016 12:30 PM PDT
Improving the Blood Collection Experience for Patient & Clinicians with the BD Vacutainer® UltraTouch™ Push Button Blood Collection Set
PRODUCT DEMO Presented by Jeff Ezell
Associate Sales Manager, BD Life Sciences
The session will demonstrate the latest in blood collection technology designed to help enhance patient comfort, improve access to difficult veins, boost efficiency and reduce needlestick injuries
SEP 14, 2016 11:00 AM PDT
Thermo Scientific LabLink xL Quality Assurance Software
PRODUCT DEMO Presented by Kris Harter
Field Implementation Specialist, Thermo Fisher Scientific
Learn how the new Thermo Scientific LabLink xL quality assurance solution turns routine QC into an exciting, automated, simple process with fast troubleshooting, peer comparison, sigma score, multiple lab management, Levey-Jennings charts, auto-QC data transfer and more.
Ketone 'Body' tests used in the diagnosis and monitoring of ketoacidosis, DKA and hyperosmolar nonketotic diabetic coma
Shane O'Neil
Director of Sales, U.S. and Canada -Acute Care & Public Health, EKF Diagnostics Inc.
Describe the various causative factors of ketosis and the physiological processes that lead to acidosis, a life threatening condition
Summarize the biochemical differences of hepatic ketone bodies and the relative strengths and weaknesses of the different 'ketone' tests available to physicians who treat acute complications of diabetes and non-diabetic causes of acidosis
Alere i Molecular Platform Demonstration Video
PRODUCT DEMO Presented by KC McGrath
Alere™ i utilizes unique isothermal nucleic acid amplification technology which does not require temperature cycling or a sample purification step. It is significantly faster than other molecular methods and more accurate than conventional rapid testing giving you the confidence to make effective patient management decisions sooner.
Defining Best Practices for Urinalysis Diagnostics in a Value-Based Healthcare System
Tim Skelton
Medical Director Core Laboratory & Laboratory Informatics, Laboratory Medicine
Sponsored By: Arkray,
Urinalysis is one the oldest, most established, and most frequently ordered laboratory tests. However, there is wide variation in the methods, processes, quality checks, specifications, and diagnostic scope in clinical use today. Dr. Skelton will describe his experience with a focused systematic effort to identify and implement best practices in all aspects of urinalysis testing at Lahey Health. Decisions on best practice were made with the goal of optimizing clinical benefit to Lahey Health's patient population and reducing the total healthcare cost attributable to the burden of diseases evaluated by urinalysis. Changes to institutional policies combined with novel application of information technology were applied to overcome perceived regulatory obstacles to optimal evidence-based clinical practice. Best practices for order design, result reporting, and data architecture and their impact on workflow efficiencies will be discussed. Recent technical advances in instrumentation allow improved diagnostic abilities that enable a redesign of the laboratory process and clinical scope of urinalysis. Data will demonstrate the impact that this type of redesign has had at Lahey Health.
After attending this session, participants will be able to:
1 Understand the variables that impact the clinical diagnostic performance of urinalysis testing
2 Identify key developments in instrumentation, information technology, and healthcare delivery that improve the value of urinalysis diagnostics
Decrease energy usage in the laboratory, with the next generation of sustainable ultra-low freezers.
PRODUCT DEMO Presented by James Daron
Commercial Manager, Ultra-Low Freezers- North America, Thermo Fisher Scientific
Ultra- Low (-80oC) temperature freezers can use as much energy in a year, as a typical American house. The -80oC freezer is most often the highest energy intensive piece of laboratory equipment you use. Up until relatively recently, electrical energy in the United States was produces in abundance and used with little or no concern regarding its resulting effects on the environment. This lack of energy concern focused Ultra-Low freezer manufactures attention on improving operational performance like temperature recovery after door openings and BTU removal, rather than a focus on reducing energy consumption.
Today, our industry is changing. Our customers are requiring more sustainable solution for all laboratory equipment. Sustainability departments and initiatives are actively looking for partners to supply equipment that used less energy, without sacrificing performance, to help meet sustainability goals.
Manufactures of -80oC freezers are now driving innovations that both improve operational performance while at the same time dramatically reducing energy consumption.
Please join Thermo Fisher Scientific as we review many of the innovation we have designed into our newest series of -80oC freezers; the Thermo Scientific™ TSX. During this presentation, you will learn how to cut your ultra-low temperature freezer energy consumption by 50%, without sacrificing performance, and be well on your way to meeting your facilities energy reduction goals.
Mobile Point-of-Care management with POC Mobile from Roche
PRODUCT DEMO Presented by William Cobb
Marketing Manager - Point of Care IT Solutions, Roche
As the interface between the laboratory and the ward, POCCs perform much of their work while out in different hospital locations. This can be challenging when managing important tasks that require a PC, like performing remote troubleshooting tasks, arranging operator training, checking the status of a device or replacing an instrument. The new POC mobile app for cobas IT 1000 enables POCCs to complete all these tasks on a smartphone or tablet, no matter where they are – assisting them with saving time and increasing productivity while on-the-go.
The cobas IT 1000 application from Roche Diagnostics provides comprehensive Point-of-Care program management tools allowing for management of system configurations, test and QC materials, operators, and Point-of-Care instruments. The cobas IT 1000 application connects the full Roche POC portfolio including Accu-Chek® Inform II, CoaguChek® XS Plus, CoaguChek® XS Pro, Urisys 1100®, and cobas® Liat as well as many instruments from other manufacturers.
Until now, Point-of-Care management required a PC or laptop. The Point-of-Care coordinator (POCC) had to remain in close proximity to their PC to effectively manage their Point-of-Care program. POC Mobile with cobas IT 1000 from Roche changes that and frees the POCC from their workstation to act while on-the-go.
AUG 10, 2016 12:30 PM PDT
Expand Your Laboratory with the Use of Mass Spectrometry
Crystal Holt
Market Development Manager - Clinical Diagnostics Americas SCIEX
The use of Liquid Chromatography Mass Spectrometry (LC-MS/MS) is becoming more prevalent in clinical research laboratories throughout the world. This technology brings an additional level of versatility with the ability for simultaneous quantitative and qualitative analysis. This session will include an introduction to LC-MS/MS for the clinical lab, encompassing both the technology and advantages.
1. Describe both the LC and MS/MS componentry that together make up an LC-MS/MS system.
2. Explain the theory of LC-MS/MS technology focusing on triple quadruple based systems.
3. Discuss how specificity and sensitivity is afforded by LC-MS/MS.
4. Summarize the laboratory requirements to implement LC-MS/MS technology.
AUG 10, 2016 11:00 AM PDT
Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections
Erik Munson, Ph.D., D(ABMM)
Assistant Professor, Marquette University
Following attendance of this virtual event, participants should appreciate the changing epidemiology of trichomoniasis and clinician ordering patterns on the basis of improved laboratory diagnostics. In addition, participants should be able to characterize the distribution of Mycoplasma genitalium infection in women and men on the basis of a new diagnostic option. Finally, attendees will be able to describe the evolution of molecular screening for human papillomavirus and application to cervical cytology.
I.Appreciate the changing epidemiology of trichomoniasis and clinician ordering patterns on the basis of improved laboratory diagnostics
II.Characterize the distribution of Mycoplasma genitalium infection in women and men on the basis of a new diagnostic option
III.Describe the evolution of molecular screening for human papillomavirus and application to cervical cytology
The Changing Landscape in Vaccine and Critical Product Storage
Joe LaPorte
Director of Product and Marketing, Panasonic Healthcare Corporation
Sponsored By: Panasonic,
This presentation explores the changing role of pharmacy grade refrigerator and freezers in the refrigerated storage of vaccine and temperature critical products. The efficacy of stored vaccine is critically dependent on storage and handling practices, including the use of reliable temperature monitoring methods and properly controlled storage systems. The absence of those protections can result in substantial waste, diminished vaccine potency, and the need for revaccination.
Currently, vaccine providers and program administrators face significant challenges as they navigate the selection and purchase of effective vaccine storage equipment. Pharmaceutical and medical grade manufacturers also face significant challenges due to changing government environmental regulations. The presentation explores what end users should look for to ensure that vaccines and critical product efficacy and safety standards are maintained and to maximize their return on investment for the long term.
Payer Perspectives: Value in Healthcare
Louis Jacques, MD
SVP & Chief Clinical Officer, ADVI
Medicare is clearly moving to a pay for value paradigm, and commercial payers continue their own march away from traditional fee-for-service payment. How can you develop and articulate a persuasive value proposition for your specific product when the payers' decisionmaking context is a much bigger picture? Successful diagnostic companies will clearly convey the impact of their test result on downstream patient outcomes. Payers expect to see evidence of patient benefit, and for diagnostic tests this means clinical utility.
ORTHO VISION® analyzer
PRODUCT DEMO Presented by Michelle Lalicata
US Marketing Manager - Transfusion Medicine, Ortho Clinical Diagnostics
The revolutionary ORTHO VISION® analyzer is a highly interactive, fully automated blood bank analyzer engineered for the specific needs of transfusion medicine. Utilizing innovative ID-MTS® gel technology, the ORTHO VISION® analyzer allows continuous access to load STAT and routine samples, reagents and consumables.
Join us for an interactive presentation on this revolutionary analyzer and learn about the first ever system that has the power to transform transfusion medicine through the benefits of responsive automation – namely:
The efficiencies of dynamic workflow management
The safety of secure monitoring technologies
An interactive partnership with a committed team of experts
JUL 13, 2016 9:00 AM PDT
Solana GAS Molecular Assay...No Culture Confirmation Required!
PRODUCT DEMO Presented by Sean Redmond
Sponsored By: Quidel,
The Solana GAS Assay is a rapid in vitro diagnostic test for the qualitative detection of Group A β-hemolytic Streptococcus (Streptococcus pyogenes) nucleic acids isolated from throat swab specimens obtained from patients with signs and symptoms of pharyngitis, such as sore throat.
The Solana GAS Assay, when performed on the Solana instrument, allows for the rapid, accurate detection of Group A Strep without the need for culture confirmation.
The assay utilizes helicase-dependent amplification (HDA) of the DNase B (sdaB) sequence and fluorescent probe-based detection in the Solana instrument to determine assay results.
A throat swab sample or an aliquot of liquid transport media is lysed by simple heat treatment, diluted, and added to a Reaction Tube containing the lyophilized HDA reagents including primers specific for the amplification of the DNAase B (sdaB) sequence as well as sequence specific probes. Competitive process control (PRC) is included in the Lysis Tube to monitor sample processing, inhibitory substances in clinical samples, reagent failure or instrument failure.
Results are displayed on the touchscreen, can be saved to the instrument, printed, and are capable of being sent to the LIS and exported through one of Solana's six USB ports. Solana GAS is supported by the power of Virena.
JUL 12, 2016 12:30 PM PDT
Answers for Healthcare Utilizing the OSOM iFOBT Assay
PRODUCT DEMO Presented by Susan Ward
Senior Global Product Manager -Point of Care, Sekisui
For the product overview/demonstration there will be an introduction to who Sekisui Diagnostic is, followed by a brief introduction to the point of care product line. The main focus will however be for one particular product the OSOM iFOBT assay. During this a PowerPoint presentation will run through the following: what is fecal occult blood, why is it important to test, what is fecal immunochemical testing, the benefits of immunochemical testing over other testing platforms, an overview over the OSOM iFOBT test, iFOB patient instruction video, OSOM training for the iFOB assay, support, and then conclusion. There will be two videos shown during this presentation on patient instruction and how the patient collects the sample and then the lab procedure video.
SeraCare Life Sciences - Innovation, Quality, Performance, and Confidence
PRODUCT DEMO Presenter by David Hall
Sr. Director Strategic Alliances, Seracare
SeraCare partners with IVD researchers and manufacturers as well as clinical laboratories to bridge the gap between today's diagnostic solutions and tomorrow's emerging technologies for molecular diagnostics, next generation sequencing and companion diagnostics. With a comprehensive portfolio of QC control and panel products, and with more than 25 years of diagnostic industry experience, SeraCare is uniquely positioned to ensure the highest level of consistency, confidence, and compliance as we jointly shape the future of medical diagnostics.
Changing Landscape of Vaccine Storage
PRODUCT DEMO Presenter by Joe LaPorte
A meta-analysis published in the journal Vaccine, including studies published in more than 20 countries, estimated that 14% to 35% of vaccines are subjected to accidental freezing – the largest source of vaccine loss. Proper storage methods and effective control of the refrigeration systems in the vaccine refrigerators and critical in protecting vaccines from freezing and from excursions outside of the normal control range of 2C to 8C which can render vaccines ineffective. Vaccines providers currently face challenges in navigating the selection and purchase of vaccine equipment. Currently an NSF committee is charged with creating a new standard for vaccine storage to make the selection simpler. This presentation is aimed at explaining the challenges, proper storage equipment selection and discussing the changes to come in the vaccine storage landscape.
Introduction to the PATHFAST, a Cardiac Biomarker Analyzer Specializing in Precise and Accurate Results Unaffected by Hemolysis
PRODUCT DEMO presented by Tim Huang
Key Accounts and Trade Marketing Manager Medical Device Group, Verbatim Americas, LLC.
Sponsored By: Vert Clinical Leader
PATHFAST is a small, benchtop cardiac marker analyzer with industry-leading precision designed for ED and stat labs. PATHFAST is the only point-of-care cardiac biomarker analyzer in the market with a 5.1% CV for Troponin I at the 99th percentile cutoff. With the flexibility to run whole blood or plasma samples, PATHFAST allows for up to six simultaneous tests in under 17 minutes. The test menu includes Troponin, CK-MB, NTproBNP, D-Dimer, hsCRP and Myoglobin, and test results are unaffected by hemolysis†, providing accurate, fast results – helping clinicians diagnose patients more effectively and efficiently.
Our goal is to not just to provide the best whole blood cardiac biomarker analyzer in the industry, but to improve the quality of patient care while simultaneously reducing costs.
PATHFAST is manufactured in Japan, from quality components, and under the strictest quality control standards.
urEssential Laboratory Professional of the Year Award Announcement and Winner Meet & Greet
urEssential Winner Announced by Megan Wimmers
The Cardinal HealthTM urEssential Award program is now in its third year and for the first time we are announcing the winner by live webcast! Please join us to meet your 2016 finalists, see the winner announcement, and find out which school will receive a $25,000 charitable contribution for the education of future clinical laboratory professionals. Stick around after the announcement for a live meet and greet with the Laboratory Professional of the Year!
JUN 08, 2016 12:30 PM PDT
Laboratory reimbursement and other regulatory issues
Elissa Passiment
Executive Vice President Emeritus, ASCLS
Sponsored By: American Society for Clinical Laboratory Science (ASCLS),
American Society for Clinical Laboratory Science (ASCLS)
The Centers for Medicare and Medicaid Services (CMS) is about to gather reimbursement data from laboratories to recalculate the clinical laboratory fee schedule. The process and potential impact of this project, as well as other new reimbursement models proposed by CMS will be discussed. We will also update attendees on the FDA laboratory developed test guidance and controversy, describe the status of CLIA activities and analyze federal government policy developments pertaining to laboratory practice.
JUN 08, 2016 11:00 AM PDT
Emerging infectious diseases - back to the future
Vickie Baselski, PhD, D(ABMM), F(AAM)
Professor, Pathology and Laboratory Medicine University of Tennessee Health Science Center
An emerging infectious disease or re-emerging infectious disease is defined by WHO as "one that has appeared in a population for the first time, or that may have existed previously but is rapidly increasing in incidence or geographic range." A 2003 IOM report identified several factors that have contributed to the emergence and re-emergence of infectious diseases. Healthcare has seen many examples of emerging infectious in the past few decades and each outbreak has presented new lessons for dealing with future outbreaks. In addition, the microbiology laboratory is challenged to serve as both sentinels for the disease activity as well as resources for testing and diagnostic information, and there are lessons to be learned here as well. This presentation will highlight several recent situations involving emerging infectious diseases, discuss the key contributing factors, identify lessons learned for the future, and describe the critical role of the laboratory in outbreak response.
Describe factors that contribute to emerging infectious diseases, and provide examples of infections related to those factors.
Describe the role of the microbiology laboratory in recognition and diagnosis of emerging infectious diseases.
Individualized Quality Control Plan (IQCP) Training
Stephanie Dean
Product Manager, Culture Media Americas
This presentation covers the "Individualized Quality Control Plan" (IQCP) implemented by The Centers for Medicare & Medicaid Services (CMS) on January 1, 2016. The guidance and concepts for IQCP are a formal representation and compilation of many of the activities currently undertaken in laboratories to ensure quality test results for patients. The three main parts of IQCP are Risk Assessment, Quality Control Plan, and Quality Assessment. IQCP permits the laboratory to customize its QC plan according to test method, environment, patient population, and personnel competency.
Upon completion of this presentation, participants should be able to:
Identify eligible test for IQCP
Identify the three sections of an IQCP
Prepare a plan for implementation of IQCP
Rapid diagnosis of strep pharyngitis: Update for clinicians
Andrew Schuman, MD, FAAP
Section Editor, Peds v2.0, Contemporary Pediatrics Member, Executive Advisory Board, Contemporary Pediatrics Clinical Assistant Professor of Pediatrics, Geisel School of Medicine at Dartmouth
Medical providers now have a number of new technologies available for the rapid diagnosis of strep pharyngitis. Dr. Schuman will present an overview of strep pharyngitis, signs and symptoms and complications with an emphasis on expediting diagnosis in the medical office. The role of the strep score with be reviewed and discussed regarding its clinical utility. Recommendations will be made for improving your current diagnostic technology.
Point-of-care hemoglobin testing: Supporting the goal of patient blood management
Regional Director, Patient Blood Management, Accumen
Patient Blood Management (PBM) is an emerging clinical concept designed to reduce unnecessary, excessive and avoidable blood transfusions. Interest in PBM has grown rapidly throughout the world as new evidence demonstrates a strong association between transfusion and a variety of healthcare care complications (infections, pulmonary injury, and mortality). Reducing transfusion exposure in hospitals has the dual benefit of significantly reducing costs while improving safety and outcomes. PBM Programs often utilize a variety of resources and technologies to optimize blood management, including point-of-care testing. Point-of-care Hemoglobin testing has been widely used in hospitals and published in the literature as an evidence based strategy to support transfusion management. This presentation will focus on practical applications of POCT Hgb to improve the recognition and management of anemia, support the paradigm shift of RBC transfusion as single units with reassessment, and optimize transfusion decision making in the anemic or bleeding patient.
Describe how optimal transfusion practice and patient blood management can result in reduced health care costs and improved patient outcomes
Define how point-of-care Hemoglobin testing can improve recognition/management of anemia and transfusion decision making in the bleeding patient
The inspector is at the door - is your QC ready?
Terese Wolek
Senior Sales Product Manager, Bio-Rad Laboratories
This presentation will outline activities from pre-inspection through the post inspection process as it relates to QC throughout your laboratory. You will be provided you a strategy on what information to have available for your unannounced inspection as well as details on the most common QC related inspection deficiencies. Come join the session so you can sail through your next inspection as it relates to QC.
1. Learn how to prepare and develop strategies for your next laboratory inspection related to QC.
2. Obtain a list of the most common inspection deficiency from The Joint Commission, CAP and COLA.
DC health care update for laboratorians
Michael Beebe
Partner/Senior VP, ADVI
I will be discussing the following subjects in my presentation:
Update from 2015
PAMA Proposed (or Final Rule)
FDA Regulation of LDTs
Change to Physician Payment and impact on diagnostic testing
What to do, what to do...with all that laboratory data
Sam Hohmann
Analytics Research Director, Center for Advanced Analytics
Big data has been with us for a long time, and tools to explore it continue to improve. Where are these data resources, how are we using them, and what are we finding as we explore them? Laboratory information systems accumulate billions of results, healthcare organizations collapse them into billions of charges for laboratory services, and healthcare management databases aggregate laboratory activity into millions of items related to labor and other expense of operating laboratories. These sources feed into gaining insight into provider ordering practices, patient safety outcomes, and operational efficiencies. Examples include CMS reimbursement incentives and Choosing Wisely campaigns to reduce waste in provider practices, both of which incorporate laboratory data in their measures. While there are almost infinite opportunities to advance patient safety and organizational efficiency, there are also risks associated with availability, use, and interpretation of big data. These and other topics will be explored in this presentation.
About Us Share
Cardinal Health improves the cost-effectiveness of healthcare.
Founded as Cardinal Foods by Robert D. Walter, Cardinal Health was initially a food wholesaler, but, through a series of acquisitions, evolved into a drug distribution company and then into the global healthcare services company it is today.
Cardinal Health improves the cost-effectiveness of healthcare. We help pharmacies, hospitals and ambulatory surgery centers, clinical laboratories and physician offices focus on patient care while reducing costs, enhancing efficiency and improving quality. We operate the nation's largest network of radiopharmacies. And, with nearly 100 years of experience, Cardinal Health provides medical products and services to many of America's most prestigious medical institutions. In fact, most U.S. hospitals use our products and services to provide care for their patients. And, now we're making this same quality and exacting standards of performance available to patients through products that help provide affordable healthcare at home.
Cardinal Health continues to evolve, applying vast resources, knowledge and healthcare expertise that allows us to create value in a dynamic, evolving industry. This understanding of what's next empowers us to make a difference for customers, patients, manufacturers, and healthcare partners across the continuum of care.
For more information, visit our website
Cardinal Health Laboratory Products
Cardinal Health Virtual Laboratory
urEssential Award Share
Cardinal HealthTM urEssential Award Program
The clinical laboratory is essential to patient care: lab test results drive more than 70% of treatment decisions. All too often, however, medical laboratory professionals are unseen and unheard; your work occurring in the background of the overall patient care picture.
Cardinal Health created the urEssential Award program to bring this critical work to the forefront and spotlight the outstanding contributions medical laboratory professionals like you make every day.
Visit our booth in the Exhibit Hall to learn more about urEssential.
2016 award winner and finalist information coming soon.
Posters Share
Graduate and Undergraduate Poster Hall – View their posters live in the poster hall on August 9, 2016
HIV-1 Infection: The Functional Importance of SDF1, CCR2 and CCR5 in Protection and Therapeutics - See Poster Abstract
Ranjeet Singh Mahla
Indian Institute of Science Education and Research
Bhopal, 462023, India
Differences in Opinion on Direct Access and Direct to Consumer Testing - See Poster Abstract
Brandy D Gunsolus, MSMLS(ASCP)CM
Effects of BDNF Genotype on Autonomic Nervous System Functioning - See Poster Abstract
Patricia Ross
William T. McCuddy
Stephanie R. Potts
Katherine Reiter
Michelle Berman
Anthony J. Porcelli, Ph.D.
April L. Harkins, Ph.D.
Kristy A. Nielson, Ph.D.
Microbial Survival on Metallic Fomites - See Poster Abstract
Kelly Wilson
Intrinsic Factor Inhibition Due to the Use of Isotretinoin - See Poster Abstract
Maikie S Sengdeng MLT(ASCP)CM
Bahar Alimadadi MLT(ASCP)CM
Ashley R Rogers MLT(ASCP)CM
Elucidation of Lipofuscin/ Melanolipofuscin Granule Composition - See Poster Abstract
Reilly Steidle
Elizabeth Gaillard, PhD
DeKalb, IL
Epigenetic Modifications of Global Methylation Following Heavy Metal Dust Exposure - See Poster Abstract
Elisa Santori
Maria L. Rodriguez
Jacob Seymour
Lacey Murphy M.S
Debora E Keil, Ph. D.
Jean Pfau, Ph. D
The Evaluation of the Measurement of Low Concentrations
of Cholesterol and Triglycerides in Chromatography Fractions with the Cobas® c311 Chemistry Analyzer - See Poster Abstract
Pacifique Munezero
William J. Korzun, Ph.D., DABCC, MT (ASCP)
Genomic characterization of the FCT-like region in S. dysgalactiae subsp. equisimilis - See Poster Abstract
Eduardo Zavala
University of Texas MD Anderson
Sponsored by Share
For information on becoming a sponsor or exhibitor, please click here.
Alere delivers reliable and actionable information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally.
For more than 50 years, ARKRAY has developed innovative diagnostic and monitoring products including automated systems for urinalysis, A1C, clinical chemistry instruments, reagents and consumables. In addition, ARKRAY is a leader in the blood glucose monitoring market with a ... dominant market share in long term care. ARKRAY continues to evolve and innovate its product lines and programs to meet the changing needs of the industry.
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The ... company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.
Beckman Coulter Life Sciences is dedicated to empowering discovery and scientific breakthroughs. The company's global leadership and world-class service and support delivers sophisticated instrument systems, reagents and services to life science researchers in academic and ... commercial laboratories, enabling new discoveries in biology-based research and development. A leader in centrifugation and flow cytometry, Beckman Coulter has long been an innovator in particle characterization and laboratory automation, and its products are used at the forefront of important areas of investigation, including genomics and proteomics.
Bio-Rad Laboratories (NYSE: BIO and BIOb) continues to play a leading role in the advancement of scientific discovery by offering a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global ... team of more than 7,300 employees and serves more than 100,000 research and industry customers worldwide through the company's global network of operations. Throughout its existence, Bio-Rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more.
HemoCue - A Division of Radiometer America, develops, produces and markets medical diagnostic products for Point-of-Care testing. The fundamental concept behind the HemoCue products is to perform important common blood and urine tests that offer lab quality results at the point ... of care without sacrificing the accuracy and precision offered by a central clinical lab. Tests that are fast and easy to perform - by anyone.
Leica Microsystems develops and manufactures microscopes and scientific instruments for the analysis of microstructures and nanostructures. Widely recognized for optical precision and innovative technology, the company is one of the market leaders in compound and stereo ... microscopy, digital microscopy, confocal laser scanning and super-resolution microscopy with related imaging systems, electron microscopy sample preparation, and surgical microscopy.
Ortho Clinical Diagnostics serves the transfusion medicine community and laboratories around the world. We're the leading provider of total solutions for screening, diagnosing, monitoring and confirming diseases early before they put lives at risk. Our single focus is to help ... hospitals, laboratories and blood centers worldwide deliver results that help patients experience a better quality of life.
Panasonic Corporation of North America today announced the formation of Panasonic Healthcare Company of North America. The newly formed company will consolidate the business operations of the former Panasonic Healthcare Group and the former Sanyo Biomedical Solutions Division ... Based in Secaucus, NJ the company will also have operations in Wood Dale, Illinois and Houston, Texas and will be led by Yoshi Yuasa. Panasonic Healthcare Company of North America is committed to providing innovative technological solutions for healthcare and life sciences needs. Focused business efforts will include the Panasonic digital hearing instruments and CardioHealth Station of the former Panasonic Healthcare Group, pharmacy automation technology and biomedical and other life science support products of Sanyo Biomedical Solutions Division. The new company will support Panasonic Corporations goal to be the No. 1 green innovation company in the electronics industry by 2018 by emphasizing energy savings and improved efficiency of healthcare operations through the use of Panasonic life science and healthcare-related products.
Quidel Corporation (Nasdaq: QDEL) is a California-based leading manufacturer of diagnostic healthcare solutions serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and ... provide economic benefits to the healthcare system.
Roche Point of Care
Roche Point of Care understands that the point of care is about being on the front lines with doctors, patients, nurses and lab managers-when you understand more about patients, you can do more for patients. As part of Roche Diagnostics, world leader in in vitro diagnostics, we ... provide state-of-the-art diagnostic solutions that not only increase medical value and testing efficiency, but help improve the lives of patients through speed to diagnosis and treatment. Because that's the point of care.
The worldwide headquarters for the pathology business is located in Torrance, California, highlighting Sakura as an integral part of the clinical and research community. Sakura has built its success and solidified its reputation by providing timely, ingenious solutions to the ... real challenges laboratories face on a day-to-day basis. Reliability, quality, value. The cornerstones of an unbeatable combination of traditions that span over a century of innovation at Sakura. Few companies can make those claims and back them up with a corporate commitment to every product and service they deliver. Sakura has a passion for the highest quality and reliability possible at a reasonable cost.
SeraCare partners with IVD researchers and manufacturers as well as clinical laboratories to bridge the gap between today's diagnostic solutions and tomorrow's emerging technologies for molecular diagnostics, next generation sequencing and companion diagnostics.
Siemens Healthcare Diagnostics is a global leader in in vitro diagnostics, providing healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor ... patients. Our innovative portfolio of performance-driven solutions and personalized customer care streamlines workflow, enhances operational efficiency, and supports improved patient outcomes. More than 14,000 employees serve our 30,000 customers in 120 countries. Our customers have access to a broad portfolio with more than 900 different tests available across multiple disease states: immunoassay, chemistry, automation, hemostasis and hematology, blood gas and electrolytes, diabetes, urinalysis, and molecular. Our innovative portfolio of performance-driven solutions, unmatched test menu of more than 900 different tests, and personalized customer care streamlines workflow and enhances operational efficiency. Our systematic, customer-centered approach to product development is constantly shaped and strengthened by listening to customers and understanding their needs. Working closely with laboratories, clinicians, and hospital administrators, we create forward-thinking products and solutions that are shaping and transforming diagnostics-improving clinical outcomes and, ultimately, helping to improve patient care.
Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner, and safer. We serve life science researchers from academic institutions and pharmaceutical industry, providing an unmatched combination of ... complete workflow solutions ranging from cryo-EM structural determination of macromolecular complexes and protein sociology, in the native state, to reconstruction of 3D architecture of tissues and cells. Our solutions help researchers unlock the mysteries of underlying protein function and cellular process and bridge the gap between basic scientific research to design of new therapies.
Help Share
Download Google Chrome Here
Download Mozilla Firefox Here
Download Microsoft Edge Here
Please update your information
Thank you for choosing Labroots. Please note that a Certificate of Attendance does NOT count towards Continuing Education Credits.
You must watch the entire webinar to receive your certificate of attendance.
You must attend the event before receiving your certificate of attendance.
You must register for the event first.
Certificate is no longer available for this event.
You must be logged in to retrieve your certificate.
Cancer Diagnostics
Lab Animals
Pre-Clinical
Process Monitoring
Spectrometry
Sexually Transmitted Disease
Waste Science
Environmental Microbiology
Blood Coagulation
High Dynamic Range Imaging
Hematologic Cancers
Laboratory Quality Control
Pre-clinical Research
Small Animal Imaging
Pharmaceutical Testing
Physical Testing
Rapid Point of Care Testing
Automated Sequencing
Troponin
Pharmacy Sciences
Drug Safety
Animal Research Health & Safety
Lab Operations
Imaging Biomarkers
Long-Read Sequencing
Pharmaceutical Microbiology
Diagnosis Management Teams
Molecular Dynamics
Liquid Handling Automation
Drug Design
Nucleic Acid Quantitation
Data Standards
Coagulation Test
Process Chemistry
Laboratory Methods
Clinical Evaluation
Swab Tube
Fluorescent Imaging
CLIA Compliance
POCT
Blood Culture
Treatment of Cancer
Physician Office Laboratory
Molecular Epidemiology
Primary Culture
Cancer Biomarker
Companion Diagnostic
Biochemical Assay
Rapid Detection Methods
Cancer Panels
Accurate Mass Measurements
Computational Pathology
Competency Testing
Coagulation Tests
Environmental Analysis
Liquid Filling
American Cancer Society (ACS)
${res[0].title}
${res[0].metadata_description}
` ); } }) $.ajax({ method: "POST", url: "/ajax/get-previous-tab", data: {eventId: wveId, eventType: eventType}, success: function(res) { $('.cycle-btn-box').append( `
` ); } }) }); })


text:
Jeannine (CD)
Lomepal (performer)
Frankrijk, Hiphop
Ne me ramène pas
Lomepal Jeanjass
Plus de larmes
1000 degrees Celcius
Lomepal Roméo Elvis
Le vrai moi
Skit roman
Lomepal Orelsan
Le lendemain de l'orage
Beau la folie
Évidemment
Ma cousin
Cinq doigts
Lomepal Katerine
Dans le livret
Idol, 2018
About Lomepal
CC BY-SA 4.0 - Image by Thesupermat
Antoine Valentinelli (born 4 December 1991 in Paris), better known by his stage name Lomepal, is a French rapper and singer from the 13th arrondissement of Paris. He has released five EPs, and two studio albums: Flip, released in June 2017, and Jeannine, released in December 2018, were certified double platinum by the SNEP.
His stage name comes from the fact that his friends always thought he was sick because of his pale complexion, hence Lomepal (for "the pale man"). His first stage name was Jo Pump. He is friends with the Belgian rapper Roméo Elvis, with whom he collaborated on the song "1000°C" for Lomepal's album Jeannine.
In 2017, he performed more than a hundred live shows and received over 100 million views on his YouTube channel.
On 25 October 2019 Antoine released the album, Amina. The album is essentially a deluxe version of his album Jeannine including all of its songs, with some having been remixed, rep…Read more on Wikipedia
Work of Lomepal in the library
Morale 2
Morale 2 luxe

redpajama_set_name: RedPajamaCommonCrawl


Lincolnshire County Council is responsible for holding the County Records.
The Lincolnshire Archives collect and enable access to materials about the county and its citizens. For more information please visit the Lincolnshire County Council Website.


Discerning drivers will appreciate the 2019 Ford Transit-250. Top features include power windows, a tachometer, variably intermittent wipers, front bucket seats, tilt and telescoping steering wheel, remote keyless entry, an overhead console, and air conditioning. Storage solutions are integrated throughout the interior, demonstrating thoughtful attention to detail. Take assurance in side curtain airbags, providing head protection in the event of a severe collision. Our knowledgeable sales staff is available to answer any questions that you might have. They'll work with you to find the right vehicle at a price you can afford. Come on in and take a test drive!


ASCL strongly criticised the remarks made in a speech by Andrew Adonis that 800 secondary schools were underperforming and "wasting pupils' talents".
John Dunford was quoted in the Daily Telegraph, Independent, the Guardian and BBC Online on 3 October as saying that this was patently untrue.
"It is quite wrong to say that all those 800 schools are giving a bad education. Many of these schools serve extremely challenging communities and many children who are new to this country."
He said that schools were being forced to change priorities to focus on maths and English.
In response to the judgement against an independent school head who was fined for health and safety issues related to a toddler's death, ASCL said that the sentence reflected the enormous burden of responsibility put on headteachers for the children in their care.
He said: "The notion of what is safe has changed over the years and schools now find themselves operating in a no-risk culture.
"Heads of both maintained and independent schools are coming under increasing pressure from health and safety legislation. Standards expected of schools are now higher than those that most parents would observe at home."
John was quoted in the Daily Mail, Western Mail, and on Sky News.
"Complete nonsense" was the way ASCL described figures put out by the Office of National Statistics in September saying that school productivity had fallen by 0.7 per cent a year since 1999.
The TES and Public Finance magazine picked up the story and ASCL's comments, which pointed out that the simplistic formula relied too heavily on exam results and failed to take into account the wider outcomes of education.


In all the parts of the world the children play as soon as the opportunity appears to them, doing it of a totally natural way. Perhaps the game is part of its lives, is one of the few things in which they can decide by themselves. The game is a present activity in all the human beings. They have identified it to the etlogos with a possible fixed landlord of behavior in the human ontognesis, that has consolidated throughout the evolution of the species. If we looked for in the origins, the contribution can be come off the game to the human species.
There is no humanity where the game does not exist. He is something that the anthropologists are shortage, and if we thought that the game goes united to the childhood, deepening envelope he we will get to consider the paper of the childhood throughout history. The test that playing it is not an invention of our days we found in old Literature and the art, in which the activities of the children are described, and in the Roman Forum rayuela taxed in the floor is one. The oldest sonajeros made of bladders of pig or throat of birds, those that filled of stones so that the produced sound stimulated the curiosity of the smallest children. Surprising often, the children play the same type of games: to rayuela, to jump to the cord, with dolls or balls. Nevertheless, the games and the toys usually are different in the different societies, depending this phenomenon on the access to diverse types of materials and the existing values related to the game. The fetter to consider the children, the game and the toys varies according to the country del that we are speaking. All the cultures do not consider the game like an important factor for the development or maturity of the boy, although the specialized investigation has demonstrated that most important that a boy can do is to play.